Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers.

Source:http://linkedlifedata.com/resource/pubmed/id/11489821

Download in:

View as

General Info

PMID
11489821